Search
for
Sort by
Research 121–150 of 1000+
- Drug Reactions Affecting Hair: Diagnosis
- Management of congenital ichthyoses: European guidelines of care, part two
- Differences in Perceptions of Beauty and Cosmetic Procedures Performed in Ethnic Patients
- 5α-Reduced glucocorticoids: a story of natural selection
- Fat, Stem Cells, and Platelet-Rich Plasma
- Nonsurgical Management of Facial Masculinization and Feminization
- Overview of Facial Plastic Surgery and Current Developments
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Hair Transplantation Update
- Aesthetic Facial Surgery for the Asian Male
- Disinfection, sterilization and operation theater guidelines for dermatosurgical practitioners in India
- Rejuvenation of the Lower Eyelid Complex
- Transtemporal Midface Lifting to Blend the Lower Eyelid-Cheek Junction
- Role of platelet rich plasma gel in the wound healing of black Bengal goat
- Scalp, Skull, Orbit, and Maxilla Reconstruction and Hair Transplantation
- Fat Transfer for the Management of Soft Tissue Trauma: The Do's and the Don'ts
- An overview of management of drug-induced hair and nail disorders
- Cosmetic Surgery in the United States: Its Past and Present
- YouTube and the implementation and discontinuation of the oral contraceptive pill: A mixed-method content analysis
- Psychology’s medicalization of male baldness
- Cosmetic Surgery Considerations in the Female Patient
- Developmental Toxicity of Levo-Alpha-Acetylmethadol (LAAM) in Tolerant Rats
- Headgear-induced temporary pressure alopecia
- Threading Through Time: Hair Sutures in Plastic and Reconstructive Surgery
- Papillon-Lefévre Syndrome: A Rare Case Report and a Brief Review of Literature
- МИКРОБИОЦЕНОЗ ЛУНОК УДАЛЕННЫХ ЗУБОВ У ПАЦИЕНТОВ С АЛЬВЕОЛИТОМ
- Microneedles-A new paradigm in transdermal delivery of therapeutic agents
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- British Cosmetic Dermatology Group
- PSS34 THE IMPACT OF POTENTIAL PILL SPLITTING ON GENERIC AND BRANDED FINASTERIDE UPTAKE